LATEST NEWS STORIES
Support Our Veterans by Joining MedTechVets Today
11 November 2024
FDA Hosts Public Workshop on Biocompatibility for Medical Devices
6 November 2024
CMS Publishes CY 2025 OPPS, ASC, Physician Fee Schedule Final Rules
1 November 2024
GAO Releases Report Urging Improved Efforts on Healthcare Price Transparency
2 October 2024
FDA Implements Reorganization Aimed to Enhance Collaboration
1 October 2024
MDMA Files Comments to FDA on Draft Guidance Regarding Diversity Action Plans
26 September 2024
FTC Files Lawsuits Against PBMs over Drug Pricing
20 September 2024
House Passes BIOSECURE Act
9 September 2024
MDMA Files Comments to CMS on CY 25 PFS and CY 25 OPPS/ASC Proposed Rules
9 September 2024
Federal Trade Commission’s Non-Compete Ban Blocked, Appeals Expected
20 August 2024
MDMA Statement on CMS’ Final TCET Notice and Guidance
8 August 2024
MDMA Responds to Request for Stakeholder Input on Next-Generation CURES Bill
2 August 2024
Shuren Departing CDRH, Dr. Michelle Tarver to Serve at Acting Director
23 July 2024
CMS Releases Medicare PFS and Hospital OPPS and ASC Payment System CY 25 Proposed Rules
10 July 2024
MDMA Submits Comment to the Cybersecurity & Infrastructure Security Agency on Reporting Requirements
1 July 2024
MDMA Statement on House Ways & Means Committee Vote to Improve Medicare Patient Access to MedTech
27 June 2024
MDMA Statement on Reintroduction of the “Improving Seniors' Timely Access to Care Act”
12 June 2024
Representatives Seek Stakeholder Input on 21st Century Cures Initiative
6 June 2024
MDMA Files Comments to CMS on the Use of Medicare Advantage Data
29 May 2024
House Budget Committee Examines Impact of Consolidation in the Health Care Ecosystem
23 May 2024
FDA Center Directors Testify Before E&C Health Subcommittee
22 May 2024
House Oversight Committee Advances “BIOSECURE Act”
15 May 2024
Bipartisan Senate Group Releases Roadmap for Artificial Intelligence
15 May 2024
White House Announces New China Tariffs Impacting Medical Products
14 May 2024
Senate Appropriations Subcommittee Examines FY 25 Budget Request for FDA
8 May 2024